Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia

BACKGROUND: The pharmacokinetic basis of magnesium sulphate (MgSO (4)) dosing regimens for eclampsia prophylaxis and treatment is not clearly established. OBJECTIVES: To review available data on clinical pharmacokinetic properties of MgSO (4) when used for women with pre‐eclampsia and/or eclampsia....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BJOG
Asıl Yazarlar: Okusanya, BO, Oladapo, OT, Long, Q, Lumbiganon, P, Carroli, G, Qureshi, Z, Duley, L, Souza, JP, Gülmezoglu, AM
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2015
Konular:
Systematic Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4737322/
https://ncbi.nlm.nih.gov/pubmed/26599617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1471-0528.13753
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller